Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Fenfang Wei"'
Autor:
Jianru Wu, Jingying Wu, Biyu Tang, Ze Zhang, Fenfang Wei, Dingbiao Yu, Limin Li, Yue Zhao, Bei Wang, Wenyu Wu, Xiang Hong
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
BackgroundPeriodontal disease is widespread among pregnant women, and it is possible that taking action to improve oral health conditions can make improvements in adverse pregnancy outcomes. Herein, we summarize the recent evidence using a network me
Externí odkaz:
https://doaj.org/article/50746b8c8cb648ae9e2863202441216d
Autor:
Jingying Wu, Jianru Wu, Biyu Tang, Xinru Wang, Fenfang Wei, Yi Zhang, Limin Li, Hongqiao Li, Bei Wang, Wenyu Wu, Xiang Hong
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
PurposeThis study aimed to characterize the safety profiles of rivaroxaban-associated suspected adverse events by mining the Food and Drug Administration Adverse Event Reporting System (FAERS).MethodsA disproportionality analysis of spontaneously rep
Externí odkaz:
https://doaj.org/article/c3d8801035aa45908a91e9315d2e5fe6
Autor:
Xin Liu, Ze Xu, Juman Ma, Aijun Zhang, Zhaohang Li, Guanpeng Qi, Zuojing Li, Fenfang Wei, Ling Zhong
Publikováno v:
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
The role of gender, age, dose and other factors in the adverse reaction process of pseudocholelithiasis caused by ceftriaxone is controversial. In this study, we further explored potential risk factors using the FAERS database.The reported odds ratio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8599c04b231808f231f0ebb47c3b61a
https://pubmed.ncbi.nlm.nih.gov/36270450
https://pubmed.ncbi.nlm.nih.gov/36270450